Meta-Analysis
Copyright ©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Dec 14, 2013; 19(46): 8770-8779
Published online Dec 14, 2013. doi: 10.3748/wjg.v19.i46.8770
Meta-analysis of Barrett’s esophagus in China
Ying Dong, Bing Qi, Xiao-Ying Feng, Chun-Meng Jiang
Ying Dong, Xiao-Ying Feng, Chun-Meng Jiang, Department of Gastroenterology, the Second Affiliated Hospital of Dalian Medical University, Dalian 116023, Liaoning Province, China
Bing Qi, Department of General Surgery, the First Affiliated Hospital of Dalian Medical University, Dalian 116011, Liaoning Province, China
Author contributions: Dong Y performed databases retrieval, data extraction, data analysis, writing the manuscript and interpretation; Qi B, Feng XY performed databases retrieval, data extraction and interpretation; Jiang CM made contributions to the study design and financial support, and provided critical comments for amendments of the manuscript.
Correspondence to: Chun-Meng Jiang, PhD, Department of Gastroenterology, the Second Affiliated Hospital of Dalian Medical University, NO.465 Zhongshan Road, Shahekou Region, Dalian 116023, Liaoning Province, China. 13940891419@163.com
Telephone: +86-411-84671291 Fax: +86-411-84668536
Received: August 14, 2013
Revised: September 23, 2013
Accepted: September 29, 2013
Published online: December 14, 2013
Core Tip

Core tip: Barrett’s esophagus (BE) is a precursor of esophageal adenocarcinoma. Western countries have published more research on BE than China has. Thus, epidemiological knowledge of BE in China is inadequate. Diagnosis and treatment of BE in China is based on western criteria, therefore, diagnosis, monitoring, and treatment of BE require more data based on the unique characteristics of patients and clinics in China. The current research analyzed 69 clinical studies to obtain a comprehensive understanding of BE in China. Results provide important guidelines that can help improve the treatment and follow-up of BE patients in China.